Addictions, Drug & Alcohol Institute

Sign Up to Get a Monthly Summary of New Opioid/Overdose Research

COSE logo

Susan Kingston of the Alcohol & Drug Abuse Institute puts out a monthly email newsletter that features the latest in opioid and overdose-related research and commentary. If you’re interested in subscribing, send an email to stopovd@uw.edu.

Here’s what was featured in the October 2019 issue:

From Local Researchers

Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington. Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, Glick SN, Hamblin M, Holcomb S, Mosse D, Oliphant-Wells T, Shim MM. Subst Abus. 2019 Aug 12:1-9. doi: View abstract.

Naloxone and Overdose Prevention

Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. Townsend T, Blostein F, Doan T, et al. Int J Drug Policy 2019 Aug 19. pii: S0955-3959(19)30209-9.  View abstract.

Naloxone urban legends and the opioid crisis: what is the role of public health? Crabtree A, Masuda JR. BMC Public Health 2019 May 30;19(1):670. doi: 10.1186/s12889-019-7033-5. Free
online
.

Narratives of people who inject drugs on factors contributing to opioid overdose. Chang JS, Behar E, Coffin PO. Int J Drug Policy 2019 Aug 20;74:26-32. View abstract.

Relay: A Peer-Delivered Emergency Department-Based Response to Nonfatal Opioid Overdose. Welch AE, Jeffers A, Allen B, Paone D, Kunins HV. Am J Public Health 2019 Oct;109(10):1392-1395. View abstract.

Justice involvement patterns, overdose experiences, and naloxone knowledge among men and women in criminal justice diversion addiction treatment. Gicquelais RE, Mezuk B, Foxman B, et al. Harm Reduct J 2019;16(1):46. doi: 10.1186/s12954-019-0317-3. Free online.

One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose. Weiner SG, Baker O, Bernson D, Schuur JD. Ann Emerg Med 2019 Jun 19. pii: S0196-0644(19)30343-9. View abstract

Focus on Pharmacies

Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Bach P, Hartung D. Addict Sci Clin Pract 2019 Sep 2;14(1):30. View abstract.

Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review. Thakur T, Frey M, Chewning B. J Am Pharm Assoc 2019 Jul 29. pii: S1544-3191(19)30320-6. View abstract.

Pharmacists’ attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature. Muzyk A, Smothers ZPW, Collins K, et al. Subst Abuse 2019 Aug 16:1-8. View abstract.